Cargando…
Changes in Biomarker Status in Metastatic Breast Cancer and Their Prognostic Value
PURPOSE: There is cumulative evidence that changes in biomarker status occur frequently during the metastatic progression of breast cancer and affect treatment response. The purpose of this study was to evaluate the frequency of biomarker changes in metastatic breast cancer (MBC) and its impact on p...
Autores principales: | Woo, Ji Won, Chung, Yul Ri, Ahn, Soomin, Kang, Eunyoung, Kim, Eun-Kyu, Kim, Se Hyun, Kim, Jee Hyun, Kim, In Ah, Park, So Yeon |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Korean Breast Cancer Society
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6769393/ https://www.ncbi.nlm.nih.gov/pubmed/31598343 http://dx.doi.org/10.4048/jbc.2019.22.e38 |
Ejemplares similares
-
Prognostic implications of regression of metastatic axillary lymph nodes after neoadjuvant chemotherapy in patients with breast cancer
por: Chung, Yul Ri, et al.
Publicado: (2021) -
Negative Conversion of Progesterone Receptor Status after Primary Systemic Therapy Is Associated with Poor Clinical Outcome in Patients with Breast Cancer
por: Ahn, Soomin, et al.
Publicado: (2018) -
Genomic profiling of multiple breast cancer reveals inter-lesional heterogeneity
por: Ahn, Soomin, et al.
Publicado: (2020) -
Changes and prognostic values of tumor-infiltrating lymphocyte subsets after primary systemic therapy in breast cancer
por: Ahn, Soomin, et al.
Publicado: (2020) -
Microinvasive Carcinoma versus Ductal Carcinoma In Situ: A Comparison of Clinicopathological Features and Clinical Outcomes
por: Kim, Milim, et al.
Publicado: (2018)